Future studies with larger cohorts, more precise genotyping methods, and detailed analyses of gene–environment interactions are warranted to further elucidate the role of COL1A2 and other genetic variants in the pathogenesis of osteoporosis and bone mineral loss. This evidence concerns the gene COL1A2 and osteoporosis.